Nc1c(-c2ccccc2-c2c(N)[n+]([O-])c3ccccc3[n+]2[O-])[n+]([O-])c2ccccc2[n+]1[O-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?